Evidence map›Paper›PMID 36778918›Full record

ArticleJournal of oncology2023

ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling.

Sijun Chen, Feijing Wu, Jiaxuan Zhang, Jianwei Zhu, Xiaorong Zhou, Xiaofei Zhi

Abstract read
In one paragraph

Article in Journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sijun ChenDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China.ORCID https://orcid.org/0000-0002-9847-3687
Feijing WuDepartment of General Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China.ORCID https://orcid.org/0000-0001-9198-7960
Jiaxuan ZhangDepartment of Trauma Center, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China.ORCID https://orcid.org/0000-0001-9892-927X
Jianwei ZhuDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China.ORCID https://orcid.org/0000-0002-2191-6339
Xiaorong ZhouDepartment of Immunology, Nantong University, Nantong 226001, Jiangsu, China.ORCID https://orcid.org/0000-0002-6120-7318
Xiaofei ZhiDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China.ORCID https://orcid.org/0000-0003-1367-7638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastrointestinal stromal tumor (GIST) originates from a pacemaker cell, the Cajal cell. However, little is known about the cancer neuroscience in GIST. In this study, we aimed to elucidate the clinical and biological roles of adrenoceptor beta 2 (ADRB2) in GIST. Methods: Immunohistochemistry was used to evaluate the expression of ADRB2 in GIST tissues. The biological effects of ADRB2 on GIST cell proliferation, migration, invasion, and apoptosis were explored using Cell Counting Kit -8, plate colony formation assay, transwell invasion assay, and flow cytometry. We also explored the growth and metastasis of xenograft tumors in nude mice. Western blotting was used to quantify protein expression and phosphorylation. Results: ADRB2 is generally highly expressed in GIST. High ADRB2 expression was significantly associated with risk level, tumor size, mitotic count, and metastasis. Overexpression of ADRB2 promoted GIST cell proliferation, migration, invasion, and apoptosis, while silencing ADRB2 expression showed the opposite effects. Furthermore, we found that silencing endogenous ADRB2 inhibited GIST progression and metastasis in nude mice. ADRB2-induced ETV1 upregulation enhanced the activation of c-KIT. Conclusion: ADRB2 plays an important role in the proliferation and metastasis of GIST and is expected to be a potential target for the treatment of GIST.

Identifiers

PMID36778918
PMCPMC9918370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.